Epigenetics of colorectal cancer: biomarker and therapeutic potential
G Jung, E Hernández-Illán, L Moreira… - Nature reviews …, 2020 - nature.com
Colorectal cancer (CRC), a leading cause of cancer-related death worldwide, evolves as a
result of the stepwise accumulation of a series of genetic and epigenetic alterations in the …
result of the stepwise accumulation of a series of genetic and epigenetic alterations in the …
[HTML][HTML] DNA methylation-based diagnostic, prognostic, and predictive biomarkers in colorectal cancer
DNA methylation is an epigenetic mechanism regulating gene expression. Changes in DNA
methylation were suggested to be useful biomarkers for diagnosis, and for the determination …
methylation were suggested to be useful biomarkers for diagnosis, and for the determination …
Epigenetic alterations in colorectal cancer: emerging biomarkers
Colorectal cancer (CRC) is a leading cause of cancer deaths worldwide. One of the
fundamental processes driving the initiation and progression of CRC is the accumulation of …
fundamental processes driving the initiation and progression of CRC is the accumulation of …
Promoter hypermethylation of tumour suppressor genes as potential biomarkers in colorectal cancer
JMK Ng, J Yu - International journal of molecular sciences, 2015 - mdpi.com
Colorectal cancer (CRC) is a common malignancy and the fourth leading cause of cancer
deaths worldwide. It results from the accumulation of multiple genetic and epigenetic …
deaths worldwide. It results from the accumulation of multiple genetic and epigenetic …
DNA methylation biomarkers in colorectal cancer: Clinical applications for precision medicine
N Fatemi, S Tierling, HA Es, M Varkiani… - … journal of cancer, 2022 - Wiley Online Library
Colorectal cancer (CRC) is the second leading cause of cancer death worldwide that is
attributed to gradual long‐term accumulation of both genetic and epigenetic changes. To …
attributed to gradual long‐term accumulation of both genetic and epigenetic changes. To …
Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA
YD Han, TJ Oh, TH Chung, HW Jang, YN Kim, S An… - Clinical …, 2019 - Springer
Background Colorectal cancer (CRC) screening can effectively reduce disease-related
mortality by detecting CRC at earlier stages. We have previously demonstrated that the …
mortality by detecting CRC at earlier stages. We have previously demonstrated that the …
[HTML][HTML] Genome-wide identification and validation of a novel methylation biomarker, SDC2, for blood-based detection of colorectal cancer
TJ Oh, N Kim, Y Moon, MS Kim, BD Hoehn… - The Journal of Molecular …, 2013 - Elsevier
Aberrant DNA methylation has shown promise as a biomarker for the early detection of
cancer. To discover novel genes frequently methylated at an early stage in colorectal cancer …
cancer. To discover novel genes frequently methylated at an early stage in colorectal cancer …
[HTML][HTML] Epigenetic regulation of autophagy in gastrointestinal cancers
The development of novel therapeutic approaches is necessary to manage gastrointestinal
cancers (GICs). Considering the effective molecular mechanisms involved in tumor growth …
cancers (GICs). Considering the effective molecular mechanisms involved in tumor growth …
Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle
To present proof-of-principle application for employing micro (mi) RNAs as diagnostic
markers for colon cancer, we carried out global microarray expression studies on stool …
markers for colon cancer, we carried out global microarray expression studies on stool …
Diagnostic microRNA markers for screening sporadic human colon cancer and active ulcerative colitis in stool and tissue
By routinely and systematically being able to perform quantitative stem-loop reverse
transcriptase followed by TaqMan® PCR expression analysis on stool and tissue samples …
transcriptase followed by TaqMan® PCR expression analysis on stool and tissue samples …